The 10-year overall survival of luminal A breast cancer patients with high expression of ARHGAP29 was significantly reduced as compared with luminal A breast cancer patients with low expression of ARHGAP29 (Threshold = 8 FPKM; ARHGAP29lown = 271; ARHGAP29highn = 209; p = 0.0141; Figure 1B). This evidence concerns the gene ARHGAP29 and breast carcinoma.